| Health / Medical Topics |
Myeloma Ig Id-KLH Conjugate Vaccine
A vaccine consisting of myeloma-specific immunoglobulin conjugated to keyhole limpet hemocyanin (KLH), an immune stimulant, with potential antineoplastic activity. Vaccination with myeloma Ig Id-KLH conjugate vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against myeloma cells, resulting in decreased tumor growth. (NCI Thesaurus)
YOU MAY ALSO LIKE
Cancer that arises in plasma cells, a type of white blood cell.
The determination of the ratio of myeloid cells compared to erythroid cells present in a sample. The measurement may be expressed as…
A myeloid sarcoma that is responding to therapy, i.e. is not progressing and possibly regressing. --2003
A tumor mass composed of myeloblasts or immature myeloid cells. It occurs in extramedullary sites or the bone.
Myeloid neoplasms occurring in individuals with Down syndrome. There is an increased risk of acute leukemias in both children and adults…
Myeloid neoplasms characterized by the rearrangement of the PDGFRB gene, most often resulting in the formation of ETV6-PDGFRB fusion transcripts. Patients usually…
